Title
Category
Credits
Event date
Cost
HSC Center for Older Adults: 2023-25 Addressing Depression in the Context of Age-Friendly Care
  • Depression
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 AOA Category 2-B
  • 1.00 ASWB
$0.00
Major depressive disorder comes under the "M" of Mentation of the Age-Friendly Health System model. This activity will discuss suicidal epidemiology, assessment, and treatment for Major Depressive Disorder. Although we see a much higher focus on suicide in younger people in the lay media, men aged 65 and older constitute the highest rate per 100,000 population.
Depression and Suicide
  • Depression
  • 2.00 AANP Pharmacology Contact Hours
  • 15.00 AMA PRA Category 1 Credit™
  • 15.00 ANCC
  • 15.00 ASWB
$90.00
Depression is a common, debilitating mood disorder. Depression is highly prevalent in medically ill populations, and many persons with depression are either unaware they need professional help or are reluctant to seek it. Although contact with the primary care setting represents a potential opportunity for timely identification and intervention, abundant evidence indicates that many patients with depression are inadequately diagnosed by nonpsychiatrist physicians, with one study showing inadequate assessment and diagnosis even after training.
Major Depressive Disorder
  • Depression
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
$0.00
Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.
ORN Fall 2023 - Opioid Use Disorder, Depression & Suicide: Overlapping Risk & Treatment Challenges
  • Depression
  • Opioid Use Disorder (OUD)
  • Suicide
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 AOA Category 1-A
$0.00
This lecture will review the prevalence and challenges in managing patients with co-occurring opioid use disorder, depression and self-injurious behavior.